This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of beta-lactamase inhibitors. These inhibitors play a critical role in combating antibiotic resistance by preventing the breakdown of beta-lactam antibiotics, such as penicillins and cephalosporins, by bacterial enzymes. The compound’s structure, featuring a diazabicyclooctane core, is key to its activity, as it mimics the transition state of the enzyme-substrate interaction, effectively blocking the enzyme’s function. Its application extends to the development of combination therapies, where it is paired with beta-lactam antibiotics to enhance their efficacy against resistant bacterial strains. Additionally, it serves as an intermediate in the production of more complex molecules designed to address multidrug-resistant infections.